RXO (NYSE:RXO) Given New $24.00 Price Target at Stifel Nicolaus

RXO (NYSE:RXOFree Report) had its target price cut by Stifel Nicolaus from $27.00 to $24.00 in a report released on Thursday morning,Benzinga reports. They currently have a hold rating on the stock.

Other equities research analysts have also issued research reports about the stock. Susquehanna decreased their price objective on shares of RXO from $16.00 to $12.00 and set a “negative” rating for the company in a research note on Tuesday, November 12th. The Goldman Sachs Group reiterated a “neutral” rating and set a $29.00 price target on shares of RXO in a report on Monday, November 18th. Jefferies Financial Group reduced their price objective on RXO from $33.00 to $30.00 and set a “buy” rating for the company in a research note on Friday, January 10th. Barclays lowered their target price on RXO from $32.00 to $30.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Finally, Wells Fargo & Company reduced their price target on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 7th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, RXO presently has an average rating of “Hold” and a consensus target price of $26.14.

Get Our Latest Stock Analysis on RXO

RXO Stock Performance

RXO stock opened at $21.46 on Thursday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.33 and a current ratio of 1.33. RXO has a twelve month low of $18.75 and a twelve month high of $32.82. The stock’s 50 day moving average is $25.79 and its 200-day moving average is $27.51.

RXO (NYSE:RXOGet Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.06. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. On average, research analysts predict that RXO will post 0.12 EPS for the current year.

Institutional Investors Weigh In On RXO

Hedge funds and other institutional investors have recently bought and sold shares of the business. Oregon Public Employees Retirement Fund boosted its holdings in shares of RXO by 1.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 32,863 shares of the company’s stock worth $783,000 after acquiring an additional 500 shares during the period. GAMMA Investing LLC lifted its holdings in RXO by 40.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after purchasing an additional 510 shares in the last quarter. Blue Trust Inc. boosted its stake in RXO by 79.7% in the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock worth $27,000 after purchasing an additional 510 shares during the period. Mutual of America Capital Management LLC grew its holdings in RXO by 2.7% during the 4th quarter. Mutual of America Capital Management LLC now owns 21,190 shares of the company’s stock valued at $505,000 after buying an additional 551 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. increased its position in shares of RXO by 68.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after buying an additional 570 shares during the period. Institutional investors own 92.73% of the company’s stock.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.